Yasmine Iddir

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

Elizabeth R. Tucker, Irène Jiménez, Lindi Chen et al. · Clinical Cancer Research · 2023 · 30 citations · Full text

The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples

Ruben Van Paemel, Charlotte Vandeputte, Lennart Raman et al. · European Journal of Cancer · 2021 · 27 citations · Full text

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study

Olivia Ruhen, Nathalie S.M. Lak, Janine Stutterheim et al. · JCO Precision Oncology · 2022 · 21 citations · Full text

Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma

Nathalie S.M. Lak, Lieke M. J. van Zogchel, Lily Zappeij‐Kannegieter et al. · JCO Precision Oncology · 2023 · 21 citations · Full text

Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving <i>ALK</i> -Targeted Therapy

Charles Bobin, Yasmine Iddir, Charlotte Butterworth et al. · Clinical Cancer Research · 2024 · 13 citations · Full text